For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
INSULIN GLARGINE: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Basaglar 100U/mL Inj Sol-Cartridge 5x3mL PkDIN 02444844 | General benefit | $84.7000per source unit | Requirements & sourcesBuild cost plan |
| Basaglar 100U/mL Inj Sol-KwikPen (80U) Pref Pen 5x3mL PkDIN 02461528 | General benefit | $84.7000per source unit | Requirements & sourcesBuild cost plan |
| Lantus-(Vial) 100U/mL Inj Sol-10mL Vial PkDIN 02245689 | Limited Use, codes 644 | $61.6900per source unit | Requirements & sourcesBuild cost plan |
| Semglee 100U/mL Inj Sol-3mL Pref PenDIN 02526441 | General benefit | $12.7668per source unit | Requirements & sourcesBuild cost plan |
| Toujeo DoubleSTAR 300U/mL Inj Sol-3mL Pref PenDIN 02493373 | General benefit | $52.8666per source unit | Requirements & sourcesBuild cost plan |
| TOUJEO SoloSTAR 300U/mL Inj Sol-1.5mL Pref PenDIN 02441829 | General benefit | $26.4333per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives